Market Mover | Tenon Medical Shares Resume Trade After Circuit Breaker to the Upside
Market Mover | Tenon Medical Shares Resume Trade After Circuit Breaker to the Upside
September 13, 2024 - $Tenon Medical (TNON.US)$ shares surged 134.32% to $10.31 on Friday.
2024年9月13日- $Tenon Medical (TNON.US)$ 股价周五大涨134.32%,达到10.31美元。
The company is preparing for the alpha launch of their new Catamaran SE SI Joint Fusion System in Q4. This system offers a smaller implant option with a 30% width reduction, catering to physicians dealing with limited space or revising failed SI joint implants.
公司计划在第四季度推出其全新的Catamaran SE SI Joint Fusion System,为医生提供30%宽度缩小的更小植入物选项,以满足空间有限或需要修复失败的SI关节植入物的医生的需求。
In addition, the company announced a public offering with a health-care focused investor for up to 1,222,850 shares of common stock and warrants at $3.68 per share. The offering is expected to generate approximately $4.5 million in gross proceeds, with funds allocated for commercial activities and general corporate use.
此外,该公司宣布与一家以医疗为重点的投资者进行公开发行,以每股3.68美元的价格发行多达1,222,850股普通股和权证。预计此次发行将获得约450万美元的总收益,资金将用于商业活动和一般企业用途。
About Tenon Medical
关于Tenon Medical
Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™️ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022 Tenon is focused on two commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, and 2) Revision procedures of failed SI Joint implants.
成立于2012年的Tenon Medical, Inc.是一家医疗器械公司,研发了Catamaran SI Joint Fusion System,采用单个坚固的钛植入物采用一种新颖的、非侵入性的SI关节处理方法。该系统具有通过髂骨和骶骨的轴向和矢状平面穿过的Catamaran™️ Fixation 设备,沿着其纵轴稳定和穿刺SI关节。Catamaran手术方法的角度和轨迹也经过设计,以提供远离关键神经和血管结构并进入最强的皮质骨的通道。自2022年10月全国推出Catamaran SI Joint Fusion System以来,Tenon将重点关注两个商业机会,包括:1)主要的SI Joint手术,和2)失败的SI Joint植入物的修复手术。